Legal & General Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Legal & General Group’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,674	Closed	-$458K	–	3453
2020 Q2	$458K	Buy	7,674 +3,971	+107%	+$245K	﹤0.01%	2191
2020 Q1	$220K	Sell	3,703 -852	-19%	-$49.7K	﹤0.01%	2269
2019 Q4	$249K	Buy	4,555 +2,322	+104%	+$86.7K	﹤0.01%	2344
2019 Q3	$63K	Hold	2,233	–	–	﹤0.01%	2666
2019 Q2	$74K	Buy	2,233 +1,351	+153%	+$42.2K	﹤0.01%	2639
2019 Q1	$30K	Hold	882	–	–	﹤0.01%	2937
2018 Q4	$24K	Buy	+882	New	+$22.7K	﹤0.01%	3017

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Legal & General Group's PRNB Position: Q3 2020 in Review

Legal & General Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 7,674 shares — an estimated $458K sold.

Legal & General Group first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $458K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Legal & General Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Legal & General Group sold 7,674 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $458K.
Legal & General Group first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Legal & General Group's Principia Biopharma Inc. Common Stock position peaked at $458K in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.